top of page
About
Committee
Consultancy
Research
T21
Publications
Medical Cannabis Working Group
Medical Psychedelics Working Group
Enhanced Harm Reduction Working Group
Community
Students
Events
Resources
Podcast
Blog
Bookshop
Drug Information
Street Drug Discussions
Training
UK
Modules
Donate
Profile
Profile
Join date: Feb 27, 2026
Posts
(1)
Feb 27, 2026
∙
5 min
The Possible Gamechanger of COMP360 for Treating Treatment-Resistant Depression
Psychiatric medicine is undergoing a seismic shift as Compass pathways announce successful results from its Phase 3 trial (COMP006).
415
0
About
Committee
Consultancy
Research
T21
Publications
Medical Cannabis Working Group
Medical Psychedelics Working Group
Enhanced Harm Reduction Working Group
Community
Students
Events
Resources
Podcast
Blog
Bookshop
Drug Information
Street Drug Discussions
Training
UK
Modules
bottom of page
